Current status and future directions of hepatocellular carcinoma-targeted nanoparticles and nanomedicine.
Vikas KumarMahfoozur RahmanPrashant GahtoriFahad A Al-AbbasiFiroz AnwarHyung Sik KimPublished in: Expert opinion on drug delivery (2020)
Remarkable outcomes have recently been observed for the therapeutic efficacy of nanocarriers with respect to a specific drug target against the treatment of HCC by existing under trial drugs.